6GFX
pVHL:EloB:EloC in complex with modified HIF-1a CODD peptide containing (3R,4S)-3-fluoro-4-hydroxyproline (ligand 13a)
Summary for 6GFX
Entry DOI | 10.2210/pdb6gfx/pdb |
Descriptor | Elongin-B, Elongin-C, von Hippel-Lindau disease tumor suppressor, ... (5 entities in total) |
Functional Keywords | protein-peptide complex, ubiquitin ligase, hypoxia inducible factor, ligase |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 4 |
Total formula weight | 43559.63 |
Authors | Castro, G.V.,Testa, A.,Ciulli, A. (deposition date: 2018-05-02, release date: 2018-07-11, Last modification date: 2024-07-10) |
Primary citation | Testa, A.,Lucas, X.,Castro, G.V.,Chan, K.H.,Wright, J.E.,Runcie, A.C.,Gadd, M.S.,Harrison, W.T.A.,Ko, E.J.,Fletcher, D.,Ciulli, A. 3-Fluoro-4-hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition by the VHL E3 Ubiquitin Ligase for Targeted Protein Degradation. J. Am. Chem. Soc., 140:9299-9313, 2018 Cited by PubMed: 29949369DOI: 10.1021/jacs.8b05807 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.83 Å) |
Structure validation
Download full validation report